Hawkins Inc. Shareholders: Ownership Structure, Brands, and Acquisition History
Last updated: Sep-2026Ownership Structure
Stakes approximate based on latest filings.
Ownership Analysis
Hawkins presents an unusual case among founder-named companies: despite carrying the Hawkins family name since 1938 and being led today by CEO Patrick Hawkins, the family's combined ownership stake sits at only roughly 5.3%, meaningfully below what would typically qualify for our Founder-Controlled Public classification. We think this genuine separation between corporate identity and ownership concentration reflects nearly nine decades of gradual share dilution and public market participation, a pattern quite different from the tightly held, supervoting structures we've seen at companies like GAMCO Investors in a prior batch. In our assessment, BlackRock's 14.09% stake, alongside meaningful positions from Kayne Anderson Rudnick Investment Management, State Street, Vanguard, and Geode Capital Management, gives Hawkins a genuinely institutional shareholder base more typical of a widely held industrial company than a family enterprise, even though the Hawkins name and continued family leadership might suggest otherwise to a casual observer. We believe this ownership structure has proven advantageous for Hawkins' recent acquisition strategy specifically: a board answerable to dispersed institutional shareholders, rather than a single controlling family, has evidently supported an accelerated pace of tuck-in deals, seven separate acquisitions since 2023, that pushed fiscal 2026 revenue past $1 billion for the first time. For Hawkins shareholders, we think the practical governance reality combines the best of both structures, genuine institutional oversight and accountability, alongside continued operational leadership from a family with generations of specific knowledge of the chemical distribution business the company was built on.
Direct Owners
Institutional Shareholders
Shareholder Analysis
BlackRock holds the largest identifiable position in Hawkins at 14.09%, followed by specialist asset manager Kayne Anderson Rudnick Investment Management at 6.84%, with State Street, Vanguard, and Geode Capital Management rounding out a top-five institutional group that collectively controls roughly 68.6% of shares outstanding. We think the presence of Kayne Anderson Rudnick, a growth-and-quality-focused active manager, among the largest holders is worth noting specifically, since it suggests genuine active investor conviction in Hawkins' business quality rather than purely passive index-fund accumulation. In our reading, the Hawkins family's combined roughly 5.3% stake, split across CEO Patrick Hawkins and family members Howard and John Hawkins, represents meaningful skin in the game without constituting anything close to voting control, a healthy alignment-without-domination structure that we think has served the company well through its recent acquisition-driven growth phase. We calculate that Hawkins' roughly 1,200 employees generated $1,083.7 million in fiscal 2026 revenue, up 11% year over year, alongside net income of $81.5 million, a genuinely strong performance that likely reflects both organic segment growth and the accretive contribution of the company's numerous recent water treatment acquisitions. For Hawkins shareholders, we believe this institutionally dominated but family-informed ownership structure provides a reasonable template for governance: professional oversight from genuinely independent large shareholders, combined with operational continuity from leadership that has deep, multi-generational familiarity with the underlying chemical distribution and water treatment businesses.
Brands, Subsidiaries & Companies Owned
| Name | Type | Description |
|---|---|---|
| WaterSurplus | Subsidiary | Membrane filtration and PFAS removal water treatment technology, including the NanoStack, ImpactRO, and NanoScope product lines, acquired in 2025 |
| PhillTech, LLC | Subsidiary | Alabama-based water treatment coagulants manufacturer acquired in 2025 |
| StillWaters Technology Inc. | Subsidiary | Alabama-based water treatment company acquired in 2025 |
| Redbird Chemical Inc. | Subsidiary | East Texas chemical distribution business acquired in 2025 |
| Aqua-Chem Inc. | Subsidiary | Nebraska and Iowa commercial pool chemistry distributor acquired in 2026 |
| Water Solutions Unlimited | Subsidiary | Water treatment chemical distributor acquired in 2023 for $75 million |
| Miami Products and Chemical Co. | Subsidiary | Water treatment chemical distributor acquired alongside Water Solutions Unlimited in 2023 |
Portfolio Analysis
Hawkins' brand architecture reflects its distribution-and-manufacturing business model more than a consumer-facing identity: the company operates primarily under its own corporate name across three segments, Water Treatment, Food and Health Sciences, and Industrial Solutions, while recently acquired businesses like WaterSurplus retain their own specialized product line names, NanoStack, ImpactRO, and NanoScope, within the broader Hawkins organizational umbrella. We think this pattern, preserving acquired technical product brands while consolidating corporate identity under Hawkins, makes sense given the company's institutional and industrial customer base, water utilities, municipalities, and manufacturers typically care more about specific technical product performance and certifications than about parent company branding. In our assessment, WaterSurplus's PFAS removal technology represents a particularly strategically significant brand addition, since per- and polyfluoroalkyl substance contamination has become an increasingly urgent regulatory and public health concern for water utilities, positioning Hawkins to capture growing demand for remediation technology through a specialized, technically credible acquired brand rather than attempting to build that capability from scratch under the generic Hawkins name. We believe the company's rapid recent acquisition cadence, five separate water treatment deals in roughly eighteen months spanning 2025 and 2026, suggests management views brand and technical capability acquisition as a faster path to market credibility in specialized water treatment niches than organic product development alone. For Hawkins shareholders, we think the practical brand risk worth monitoring is integration coherence: as the roster of acquired water treatment technologies and regional distribution businesses continues growing, management will need genuine discipline to ensure customers can navigate an increasingly complex portfolio of specialized capabilities under the Hawkins umbrella.
Market Share & Competitors
Bubble size reflects relative market share.
| Company | Market Share | Revenue | Key Strength |
|---|---|---|---|
| Brenntag SE | N/A | $16.4B FY2025 | World's largest chemical distributor, offering far broader global scale than Hawkins |
| Chemtrade Logistics Income Fund | N/A | N/A FY2025 | Canadian specialty chemicals and water treatment company competing in overlapping water treatment markets |
| Univar Solutions | N/A | N/A FY2025 | Major chemical distributor taken private by Apollo Global Management in 2023 |
| Hawkins ★ | N/A | $1,083.7M FY2026 | Minnesota-based specialty chemical distributor and manufacturer spanning water treatment, food and health sciences, and industrial solutions |
Competitive Analysis
Hawkins' $1,083.7 million in fiscal 2026 revenue looks modest next to Brenntag SE's roughly $16.4 billion in global sales, though that scale gap reflects Brenntag's position as the world's largest chemical distributor operating across dozens of countries rather than any fundamental competitive weakness in Hawkins' more geographically focused United States business. We think Chemtrade Logistics Income Fund represents a more instructive direct comparison, a Canadian specialty chemicals and water treatment company competing in overlapping product categories, though at a generally smaller scale that positions both firms as regional specialists rather than global consolidators. In our assessment, the 2023 acquisition of Univar Solutions by Apollo Global Management, taking a roughly $10 billion-revenue chemical distributor private, offers a useful signal about the broader competitive landscape: private equity has identified genuine consolidation value in chemical distribution, meaning Hawkins' continued public-market, family-adjacent leadership structure represents a somewhat different strategic path than some of its larger peers have chosen to pursue. We believe Hawkins' core competitive advantage lies precisely in its disciplined, smaller-scale acquisition strategy within Water Treatment, building genuine technical differentiation in areas like PFAS remediation through targeted deals rather than attempting to compete head-on with Brenntag's global distribution scale. For Hawkins shareholders, we think the central competitive question is whether the company's rapid recent acquisition pace, seven deals in roughly three fiscal years, can continue finding attractive, reasonably priced targets in an increasingly consolidating water treatment and specialty chemical distribution industry where larger players like Brenntag and private equity-backed competitors are also actively pursuing M&A.
Acquisitions
Bubble size reflects relative deal value.
| Company Acquired | Deal Value | Year | Description |
|---|---|---|---|
| Water Solutions Unlimited | $75.0M | 2023 | Acquired the water treatment chemical distributor, adding six water treatment locations |
| Miami Products and Chemical Co. | N/A | 2023 | Acquired alongside Water Solutions Unlimited, adding water treatment distribution capacity on undisclosed terms |
| WaterSurplus | N/A | 2025 | Acquired the membrane filtration and PFAS removal technology provider on undisclosed terms |
| PhillTech, LLC | N/A | 2025 | Acquired the Alabama-based water treatment coagulants manufacturer on undisclosed terms |
| StillWaters Technology Inc. | N/A | 2025 | Acquired the Alabama-based water treatment company on undisclosed terms |
| Redbird Chemical Inc. | N/A | 2025 | Acquired the East Texas chemical distribution business on undisclosed terms |
| Aqua-Chem Inc. | N/A | 2026 | Acquired the Nebraska and Iowa commercial pool chemistry distributor on undisclosed terms |
Acquisitions Analysis
Hawkins has pursued an unusually consistent and disciplined acquisition strategy centered almost entirely on its Water Treatment segment, completing seven identifiable deals since 2023 without a single large, transformative purchase among them. We think the 2023 acquisition of Water Solutions Unlimited for $75 million, the only deal in this recent run with a disclosed dollar value, set the tone for what followed: targeted, bolt-on purchases of regional water treatment distributors and specialized technology providers rather than an attempt to buy scale through one dominant transaction. In our assessment, the 2025 additions of WaterSurplus, PhillTech, StillWaters Technology, and Redbird Chemical, followed by Aqua-Chem in 2026, demonstrate genuine strategic focus: each deal added either geographic reach into new states, Alabama, East Texas, Nebraska, and Iowa, or specialized technical capability like WaterSurplus's PFAS remediation technology, rather than simply consolidating existing overlapping operations. We note that most of these deal values remain undisclosed, consistent with the modest scale typical of tuck-in acquisitions that don't individually meet public disclosure thresholds, though the cumulative effect has been substantial: Water Treatment now represents roughly half of Hawkins' total revenue and helped push the company past $1 billion in annual sales for the first time in fiscal 2026. For Hawkins shareholders, we believe this acquisition pattern, frequent, disciplined, and geographically targeted rather than occasional and transformative, reflects a genuinely repeatable growth playbook that management appears positioned to continue executing as consolidation opportunities remain available in the fragmented regional water treatment distribution market.
Acquisition Timeline
Merger & Spin-off History
Merger & Spin-off Analysis
Hawkins' structural history over the past three fiscal years is defined almost entirely by a sequence of small, similarly structured tuck-in acquisitions rather than any single defining merger or corporate reorganization, a pattern that distinguishes the company from many of its larger chemical industry peers that have pursued transformative combinations. We think the absence of any major merger, spinoff, or ownership restructuring event in Hawkins' recent history reflects genuine strategic consistency: management has evidently concluded that accumulating specialized regional water treatment capability through frequent smaller deals better serves shareholders than pursuing a single large, integration-risky combination. The pace itself tells a story worth noting, two acquisitions in 2023, four in 2025, and one already in 2026, suggesting Hawkins has developed genuine organizational muscle memory for sourcing, evaluating, and integrating similarly sized targets efficiently rather than treating each deal as a novel, resource-intensive undertaking. We believe this consistent cadence has directly enabled Hawkins' recent financial milestone, crossing $1 billion in annual revenue for the first time in fiscal 2026, demonstrating that disciplined, repeatable small-scale M&A can compound into meaningful scale over a relatively short multi-year window. For Hawkins shareholders, we think this history offers a useful template for evaluating future growth: rather than watching for one large transformative deal, the more relevant signal is whether management can sustain its demonstrated ability to consistently identify and integrate smaller, strategically coherent water treatment and specialty chemical acquisitions.
Ownership History
Ownership History Analysis
Hawkins began in 1938 as a small-scale Minnesota chemical distribution business offering just a dozen products, a modest starting point relative to the $1,083.7 million diversified specialty chemical company it has become across nearly nine decades of operation. We think the company's evolution from that founding base into today's three-segment structure, Water Treatment, Food and Health Sciences, and Industrial Solutions, reflects a long pattern of steady diversification well before the recent acquisition acceleration, suggesting the current M&A-driven growth phase builds on genuinely deep organizational experience rather than representing a sudden strategic pivot. The persistence of Hawkins family leadership through multiple generations, culminating in current CEO Patrick Hawkins, alongside family members Howard and John Hawkins, illustrates a company whose operational culture has remained closely tied to its founding name even as broad public ownership has diluted the family's actual equity stake to roughly 5.3%. We believe fiscal 2026's milestone of surpassing $1 billion in annual revenue for the first time represents the clearest recent validation of Hawkins' long-term strategy, arriving specifically on the strength of the company's accelerated water treatment acquisition program rather than any single transformative event. For Hawkins shareholders, the nearly nine-decade arc from a tiny Minnesota chemical distributor to a billion-dollar diversified specialty chemical company illustrates how sustained, patient operational discipline, punctuated by an increasingly active recent acquisition strategy, can produce genuine long-term compounding without ever requiring dramatic ownership upheaval along the way.
Ownership Explained
Hawkins has been a widely held public company since well before its recent growth acceleration, with no single shareholder or family controlling the business despite bearing the Hawkins family name. Institutional investors collectively hold roughly 68.6% of shares, led by BlackRock at 14.09%, Kayne Anderson Rudnick Investment Management at 6.84%, and State Street at 5.09%, while members of the Hawkins family, including current CEO Patrick Hawkins, hold a combined stake of only about 5.3%, a meaningful but distinctly non-controlling position. Patrick Hawkins leads the company as President and Chief Executive Officer, overseeing a business that crossed $1 billion in annual revenue for the first time in fiscal 2026 after an unusually active run of water treatment acquisitions. The Nasdaq-listed company, trading under ticker HWKN, now organizes its operations across Water Treatment, Food and Health Sciences, and Industrial Solutions segments, with Water Treatment having grown into roughly half of total revenue.
Because no single investor or family controls Hawkins despite its founding-family name, the company's board and management answer to a genuinely dispersed institutional and retail shareholder base rather than to any dynastic controlling interest, a structure that arguably provides more conventional governance accountability than the family-name association might initially suggest. That dispersed ownership hasn't slowed the company's recent acquisition pace, however: the board has evidently supported CEO Patrick Hawkins' strategy of accumulating smaller water treatment and industrial chemical distribution businesses at a rapid clip, seven deals across just three fiscal years. For shareholders, this means Hawkins functions as a genuinely professionally managed public company whose growth strategy happens to be led by a family member with deep institutional knowledge of the business, rather than a closely held family enterprise that simply carries public shares, a distinction that matters for anyone evaluating governance risk or succession planning at the company.